UniProt ID | Protein Name ▲ | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7F8R336 | P2X purinoceptor |
|
1 | 0 |
|
A0A7F8R335 | P2X purinoceptor |
|
1 | 0 |
|
A0A2U3Y028 | P2X purinoceptor |
|
1 | 0 |
|
A0A2U3YLH3 | P2X purinoceptor |
|
1 | 0 |
|
A0A7F8RWP6 | P2X purinoceptor 2 isoform X5 |
|
1 | 0 |
|
A0A7F8R598 | P2X purinoceptor 4 isoform X4 |
|
1 | 0 |
|
A0A2U3YCJ7 | Pannexin |
|
1 | 0 |
|
A0A2U3YUZ9 | Pannexin-3 |
|
1 | 0 |
|
A0A7F8QIH4 | Paraoxonase |
|
2 | 0 |
|
A0A2U3XGV9 | Paraoxonase |
|
2 | 0 |
|
A0A7F8QLF4 | Paraoxonase |
|
2 | 0 |
|
A0A2U3XGV5 | Paraoxonase |
|
2 | 0 |
|
A0A7F8QIK4 | Paraoxonase |
|
2 | 0 |
|
A0A7F8RT43 | Peptidyl-glycine alpha-amidating monooxygenase isoform X1 |
|
1 | 0 |
|
A0A7F8RT93 | Peptidyl-glycine alpha-amidating monooxygenase isoform X10 |
|
1 | 0 |
|
A0A2U3XAJ8 | Peptidyl-glycine alpha-amidating monooxygenase isoform X11 |
|
1 | 0 |
|
A0A7F8RSE1 | Peptidyl-glycine alpha-amidating monooxygenase isoform X12 |
|
1 | 0 |
|
A0A7F8RSF9 | Peptidyl-glycine alpha-amidating monooxygenase isoform X13 |
|
1 | 0 |
|
A0A7F8RSG9 | Peptidyl-glycine alpha-amidating monooxygenase isoform X14 |
|
1 | 0 |
|
A0A7F8RRY2 | Peptidyl-glycine alpha-amidating monooxygenase isoform X15 |
|
1 | 0 |
|
A0A7F8RTD7 | Peptidyl-glycine alpha-amidating monooxygenase isoform X16 |
|
1 | 0 |
|
A0A7F8RSG8 | Peptidyl-glycine alpha-amidating monooxygenase isoform X17 |
|
1 | 0 |
|
A0A7F8RTF9 | Peptidyl-glycine alpha-amidating monooxygenase isoform X2 |
|
1 | 0 |
|
A0A7F8RRS1 | Peptidyl-glycine alpha-amidating monooxygenase isoform X3 |
|
1 | 0 |
|
A0A2U3XA88 | Peptidyl-glycine alpha-amidating monooxygenase isoform X4 |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025